~~<i id='05B575ABA9'><strike id='05B575ABA9'><tt id='05B575ABA9'><pre id='05B575ABA9'></pre></tt></strike></i>~~

Home» explore» fashion

fashion

author：comprehensive 2025-10-04 06:07:19 Page View：32

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In same hospitals, Black patients receive fewer opioids than white patients
Next article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

leisure time

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

Elon Musk announces 'temporary limits' for reading Twitter posts

0:53TheTwitterlogoisseenonaphoneinthisphotoillustrationinWashington,D.C.AlastairPike/AFPviaGettyImag

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

ResidentsoftheJeninrefugeecampfledtheirhomesastheIsraelimilitarypressedaheadwithanoperationinthearea